Amneal Pharmaceuticals, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
AMRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
400 Crossing Boulevard, 3 Rd Floor, Bridgewater, NJ

Insiders trading volume in the past year

Amneal Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Tushar Patel 10%+ Owner $406M -$41.8M -9.33% Mar 14, 2025
Chintu Patel Co-CEO, Director $237M Mar 3, 2025
Chirag K. Patel President & Co-CEO, Director $206M Mar 3, 2025
Dipan Patel Member of 13D Group $111M Nov 7, 2023
Tpg Gp A, Llc Former 10% Owner $50.9M Dec 12, 2022
Gautam Patel Director $12.9M -$3.95M -23.4% Jun 16, 2025
Paul M. Meister Director $6.57M May 5, 2025
Tasos Konidaris Executive Vice President & CFO $4.34M -$5.55M -56.2% Aug 13, 2025
Andrew S. Boyer Executive Vice President $4.16M -$4.03M -49.2% Aug 20, 2025
Nikita Shah Executive Vice President $3.96M -$2.66M -40.2% Aug 22, 2025
Joseph Todisco Executive Vice President $2.94M May 7, 2022
Ted C. Nark Director $2.86M May 5, 2025
Jason B. Daly EVP, Chief Legal Officer $2.76M -$1.48M -34.9% Aug 12, 2025
Jeffrey P. George Director $2.6M May 5, 2025
Gustavo Pesquin Title: Executive Vice President, Chief Commercial Officer - Specialty $2.54M Sep 6, 2022
J. Kevin Buchi Director $2.53M May 5, 2025
Shlomo Yanai Director $2.4M May 5, 2025
John Kiely Director $2.08M -$818K -28.2% Aug 27, 2025
Emily Peterson Alva Director $1.77M -$712K -28.7% May 5, 2025
Deborah M. Autor Director $785K -$334K -29.9% May 5, 2025

Recent Insider Transactions by Companies or Individuals for Amneal Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.